MedPath

BAYER AG

BAYER AG logo
🇩🇪Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
Clinical Trials
Related News

Evaluation of the Stinging Potential of Products in Human Eyes

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: BAY987516, Y55-170
Drug: BAY987516, X72-151
Drug: BAY987516, Y49-034
Drug: Standard shampoo mixture (control)
First Posted Date
2016-08-19
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
21
Registration Number
NCT02872194

To Test for Photo Allergy Reaction of Sunscreens

Not Applicable
Completed
Conditions
Photoallergy
Interventions
Drug: SPF 50 Y65 110 (BAY987519)
Drug: SPF 50 Y51 002 (BAY987519)
Drug: SPF 15 V27 104 (BAY987519)
Drug: Sodium chloride [NaCl]
First Posted Date
2016-08-19
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
56
Registration Number
NCT02872220

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: BAY 987519
Drug: SPF 15 Control
First Posted Date
2016-08-19
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
6
Registration Number
NCT02872233

Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: BAY98751 (Y65-110)
Drug: BAY 98751 (Y65-102)
Drug: BAY 98751 (Y65-106)
Drug: Standard shampoo mixture (Control)
First Posted Date
2016-08-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
65
Registration Number
NCT02869113

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

First Posted Date
2016-08-12
Last Posted Date
2023-11-07
Lead Sponsor
Bayer
Target Recruit Count
99999
Registration Number
NCT02864758
Locations
🇫🇷

Many Locations, Multiple Locations, France

Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms

Phase 1
Completed
Conditions
Post-menopausal Vasomotor Symptoms
Interventions
Drug: Placebo (for BAY3427080)
Drug: BAY3427080
First Posted Date
2016-08-12
Last Posted Date
2021-02-16
Lead Sponsor
Bayer
Target Recruit Count
76
Registration Number
NCT02865538
Locations
🇺🇸

QPS/MRA (Miami Clinical Research), Miami, Florida, United States

🇺🇸

Avail Clinical Research, DeLand, Florida, United States

🇺🇸

ICON Clinical Research Unit, San Antonio, Texas, United States

Sun Protection Factor (SPF) Assay

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: BAY 987517
Drug: SPF 15 Control
First Posted Date
2016-08-05
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
12
Registration Number
NCT02857725

Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: BAY 987519, SPF 50, Y51-002
Drug: BAY 987519, SPF 50, P04-147
First Posted Date
2016-08-05
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
98
Registration Number
NCT02857478

Sun Protection Factor (SPF) - Static and Water Resistant Assay

Not Applicable
Completed
Conditions
Sunscreen Agents
Interventions
Drug: BAY 987519
Drug: SPF 15 Control
First Posted Date
2016-08-05
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
12
Registration Number
NCT02857738

Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes

Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Drug: Control
Drug: BAY987521
First Posted Date
2016-08-03
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
23
Registration Number
NCT02854137
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy